| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, University of Virginia Charlottesville, Virginia, 22908
Correspondence: Address requests for reprints to: Oleh G. Pankewycz, M.D., Renal Division, Department of Medicine, Box 133, Health Sciences Center, University of Virginia, Charlottesville, Virginia 22908.
Abstract
I. Introduction: CYTOKINES are molecularly distinct secretory proteins recognized by their common function as intercellular signals. In contrast to hormones, cytokines influence cellular activities largely within confined environs in an autocrine or paracrine fashion and infrequently achieve detectable levels in the circulation. Many cytokines were initially described as cellular "factors" or "activities" contained within experimental tissue culture supernatants. The advent of molecular biology has allowed for the identification, isolation, and characterization of individual cytokine genes and consequently the expression of virtually unlimited quantities of purified protein. Members of the cytokine family include interleukins (IL) (lymphokines and monokines), interferons (IFN), colony-stimulating factors, and peptide growth factors (1). In general, cytokines are glycoproteins of 100–200 amino acid residues. Most cytokines are translated along with an aminoterminal signal peptide that directs the polypeptide chain to the endoplasmic reticulum for processing and secretion. Exceptions to this process are the cytokines IL-l
and IL-1β (2). These proteins lack signal sequences, yet are secreted. In addition, they can bind to the plasma membranes of their cells of origin in a bioactive precursor form (2). The regulatory signals controlling cytokine transcription, translation, and secretion also differ among the various cytokines. For example, the IL are tightly regulated by specific activation events that occur within a limited number of cell types (3). In contrast, the interferons and growth factors are ubiquitously produced by many cell types in response to a variety of stimuli including injury, viral infection, and metabolic disturbances.
Footnotes
* Recipient of a 1991 National Research and Development Award sponsored by the American Diabetes Association.
This article has been cited by other articles:
![]() |
M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics J. Immunol., March 1, 2005; 174(5): 2746 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zoppini, G. Faccini, M. Muggeo, L. Zenari, G. Falezza, and G. Targher Elevated Plasma Levels of Soluble Receptors of TNF-{alpha} and Their Association with Smoking and Microvascular Complications in Young Adults with Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3805 - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gurlo, K. Kawamura, and H. von Grafenstein Role of Inflammatory Infiltrate in Activation and Effector Function of Cloned Islet Reactive Nonobese Diabetic CD8+ T Cells: Involvement of a Nitric Oxide-Dependent Pathway J. Immunol., December 1, 1999; 163(11): 5770 - 5780. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Begue, A. Mirza, T. Compton, R. Gomez, and A. Vargas Helicobacter pylori Infection and Insulin Requirement Among Children With Type 1 Diabetes Mellitus Pediatrics, June 1, 1999; 103(6): 83e - 83. [Abstract] [Full Text] |
||||
![]() |
H.-S. Jun, C.-S. Yoon, L. Zbytnuik, N. van Rooijen, and J.-W. Yoon The Role of Macrophages in T Cell-mediated Autoimmune Diabetes in Nonobese Diabetic Mice J. Exp. Med., January 18, 1999; 189(2): 347 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Erondu, B. Toland, M. Boes, B. Dake, D. R. Moser, and R. S. Bar Bovine Insulin-Like Growth Factor Binding Protein-3: Organization of the Chromosomal Gene and Functional Analysis of Its Promoter Endocrinology, July 1, 1997; 138(7): 2856 - 2862. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |